In the current work, an aberrant increase in CREB1 phosphorylation was observed in MDR cells, and inhibition of CREB1 decreased ABCB1 expression and activity, indicating that CREB1 is a viable target for MDR reversal in cancer therapy. Here, CREB1 is linked to cancer.